Remepy

Found 2 recent publications

Aug 12, 2026

Startups

Michal Tsur's startup Remepy raises $36 million for the development of hybrid drugs

Remepy has raised $36 million in a Series A funding round. The startup develops hybrid drugs that combine prescription medication with AI-based therapeutic applications.

14:57Geektime

Startups

$36 million for the Israeli startup that connects drugs with code

Israeli startup Remepy has raised $36 million in a Series A funding round. The company is developing "hybrid drugs" that combine traditional medication with digital code to enhance treatment efficacy.

Showing latest 50 articles for this tag